Physician profile
Ivane Chua
NPI 1922325760
$9,923.39
in general payments reported to CMS, 2019-2025
13 companies · $1,392 in 2025
The $1,392 reported for 2025 was more than what 77% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,436 · 2020: $286 · 2021: $17.93 · 2022: $4,922 · 2023: $1,187 · 2024: $682 · 2025: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,268 · Travel and Lodging: $993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,268.05 |
| Travel and Lodging | $993.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,732.31 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $1,382.52 | 2023-2025 | Interstim, Minimed 780g |
| Davol INC. | $1,050.28 | 2020-2025 | Phasix Mesh |
| Medtronic USA, INC. | $810.97 | 2019-2020 | |
| Biom'Up Sa | $196.12 | 2019 | |
| Stryker Corporation | $173.39 | 2024 | 1788 |
| Integra Lifesciences Corporation | $157.21 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Edwards Lifesciences Corporation | $146.03 | 2019 | |
| Thd America, INC. | $136.38 | 2025 | |
| Ethicon US, LLC | $60.93 | 2021-2024 | Echelon Flex |
| Prescient Surgical | $42.54 | 2019 | |
| Celgene Corporation | $20.39 | 2024 | Zeposia |
| Olympus America INC. | $14.32 | 2023 | Endoclot Phs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivane Chua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.